BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11916069)

  • 1. The mechanism of action of angiostatin: can you teach an old dog new tricks?
    Moser TL; Stack MS; Wahl ML; Pizzo SV
    Thromb Haemost; 2002 Mar; 87(3):394-401. PubMed ID: 11916069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
    MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
    Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
    O'Reilly MS
    EXS; 1997; 79():273-94. PubMed ID: 9002223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
    You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
    Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.
    Abad MC; Arni RK; Grella DK; Castellino FJ; Tulinsky A; Geiger JH
    J Mol Biol; 2002 May; 318(4):1009-17. PubMed ID: 12054798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
    Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiostatin induces mitotic cell death of proliferating endothelial cells.
    Hari D; Beckett MA; Sukhatme VP; Dhanabal M; Nodzenski E; Lu H; Mauceri HJ; Kufe DW; Weichselbaum RR
    Mol Cell Biol Res Commun; 2000 May; 3(5):277-82. PubMed ID: 10964751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
    Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
    In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiostatin. A biological inhibitor of tumor angiogenesis].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 1997 Mar; 122(13):413-4. PubMed ID: 9138915
    [No Abstract]   [Full Text] [Related]  

  • 10. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen.
    Heidtmann HH; Nettelbeck DM; Mingels A; Jäger R; Welker HG; Kontermann RE
    Br J Cancer; 1999 Dec; 81(8):1269-73. PubMed ID: 10604721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiostatin and angiostatin-related proteins.
    Soff GA
    Cancer Metastasis Rev; 2000; 19(1-2):97-107. PubMed ID: 11191071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma.
    Levine HA; Pamuk S; Sleeman BD; Nilsen-Hamilton M
    Bull Math Biol; 2001 Sep; 63(5):801-63. PubMed ID: 11565406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
    Sharma MR; Rothman V; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis.
    Benelli R; Morini M; Brigati C; Noonan DM; Albini A
    Int J Oncol; 2003 Jan; 22(1):87-91. PubMed ID: 12469189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated.
    Wahl ML; Kenan DJ; Gonzalez-Gronow M; Pizzo SV
    J Cell Biochem; 2005 Oct; 96(2):242-61. PubMed ID: 16094651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiostatin.
    Cao Y; Xue L
    Semin Thromb Hemost; 2004 Feb; 30(1):83-93. PubMed ID: 15034800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The anti-angiogenesis effect of plasminogen kringle 5].
    Cai WB; Liu QP; Gao GQ
    Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):159-62. PubMed ID: 15285426
    [No Abstract]   [Full Text] [Related]  

  • 18. What the structure of angiostatin may tell us about its mechanism of action.
    Geiger JH; Cnudde SE
    J Thromb Haemost; 2004 Jan; 2(1):23-34. PubMed ID: 14717962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of carbohydrate on angiostatin in the treatment of cancer.
    Pirie-Shepherd SR
    J Lab Clin Med; 1999 Dec; 134(6):553-60. PubMed ID: 10595781
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation.
    Benelli R; Morini M; Carrozzino F; Ferrari N; Minghelli S; Santi L; Cassatella M; Noonan DM; Albini A
    FASEB J; 2002 Feb; 16(2):267-9. PubMed ID: 11772950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.